AbbVie | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.25B 40M 2025-06
Abbott USD 3.09B 39M 2025-06
ALKERMES USD 153.87M 17.83M 2025-06
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eisai JPY 100.16B 6.34B 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
J&J USD 5.89B 777M 2025-06
Medtronic USD 2.7B 17M 2025-04
Merck USD 2.63B 104M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Pacira USD 77.19M 9.58M 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Pfizer USD 3.42B 406M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
UCB EUR 1.29B 221M 2024-12
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
United Therapeutics USD 212.5M 42.4M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06
Zoetis USD 617M 54M 2025-06


AbbVie Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.